COVID-19 information hub
SHPA is constantly monitoring the evolving situation surrounding the impact of coronavirus 2019 (COVID-19), as the health and safety of SHPA members and staff is paramount.
- COVID-19 Hospital Pharmacy capacity snapshots A series of surveys to keep the federal government informed of the hospital systems capacity during the pandemic
- COVID-19 Hospital Pharmacy Preparation Checklist Is your department prepared?
- COVID-19 Hospital Pharmacy Relief Register Sign up to assist hospital workforce shortages
- COVID-19 Hospital Pharmacy Relief: Introductory Training For those with <6 months hospital experience
- COVID-19 Hospital Pharmacy ICU Upskilling Package New ICU upskilling available
- COVID-19 member forum Share learnings, warnings and advice
- COVID-19 webinar series All free and open access
- New COVID-19 resource update to AIDH8 New section on optimal management of injectable medicines for Australians with COVID-19 disease
- COVID-19 Quick Guides To help navigate newly authorised emergency supply provisions relating to emergency supply of medicines and digital image prescriptions
- Example 4-bed HDU imprest list For sites setting up new and temporary HDUs needing guidance on imprest items
- Advice specific to states and territories
- Advice on medicine supply
- SHPA national and Branch events
- Supporting our members
- Ahpra announcements relating to COVID-19
- Related SHPA news
- SHPA office closure
Commencing in mid-April, SHPA is undertaking a series of surveys of hospital access to medicines and the hospital pharmacy workforce in order to ensure the Federal Government has a good understanding of the system’s capacity during the COVID-19 pandemic, and to complement other information gathering activities.
The rolling surveys are emailed weekly to Directors of Pharmacy on Thursday evenings to be completed Friday mornings, as an indicative report of changing capacity to support high-quality patient care. Each survey will repeat the same questions and should not take longer than 10 minutes utilising a pharmacy stock report. All results will be aggregated and kept confidential, with trends and broad findings communicated regularly to the Department of Health.
Informed by twice weekly Director of Pharmacy / Chief Pharmacist COVID-19 Management Meetings, SHPA is maintaining a centralised COVID-19 Hospital Pharmacy Preparation Checklist resource.
The checklist is not a strict guideline, but a live snapshot of potential issues and ideas related to maintaining patient care and staff wellbeing during the management of the COVID-19 pandemic in Australian hospital pharmacy.
The purpose of the resource is to help departments with three key strategic goals during the evolving pandemic: reducing cross-infection, protecting and sustaining the workforce and maintaining optimal treatment of all patients.
The COVID-19 Hospital Pharmacy Preparation Checklist resource will be timestamped and regularly circulated to SHPA's Director of Pharmacy / Chief Pharmacist distribution list.
SHPA is collecting details from ACT, NT, SA, Tasmania, and WA-based pharmacists, technicians and pharmacy students who are interested in being listed on a database of staff willing to work with sites suffering a staff shortage due to the COVID-19 pandemic. You will need your details and a CV, and a police check and working with children check if available.
- Register with the New South Wales Government →
- Register with the Queensland Government → (Pharmacists, follow the link for Allied Health; Technicians and students, follow the link for Operational staff)
- Register with the Victorian Government → (Pharmacists, select Allied Health, then select Pharmacist as your profession; Technicians, students and others, select Other as your profession, and specify in the available field.)
All pharmacists, technicians and pharmacy students with less than six months’ hospital experience, who have signed up to the COVID-19 Hospital Pharmacy Relief Register, are welcome to undertake free introductory training on working in the hospital pharmacy setting. The training contains five hours of self-directed online learning
Please note: signing up the Relief Register and/or completing of the associated Introductory Training does not mean you will be required for hospital relief work, as this will be coordinated based on location and skills mix of the hospitals requiring additional support.
COVID-19 Hospital Pharmacy ICU Upskilling Package
SHPA has launched the COVID-19 Hospital Pharmacy ICU Upskilling Package, a free program of learning that provides a rapid introduction to hospital pharmacy in the intensive care setting, including medicine use, sepsis management, renal replacement therapy and the latest guidelines, considerations and possible treatment options for the management of COVID-19.
*UPDATE* Following a comprehensive review by SHPA's Critical Care Leadership Committee, the content of this package has been classified into three categories – Essential, Further Learning, and In-depth Learning – to help users navigate through the resource.
Recent updates, additions and expansions include:
- additional recommended resources from Aus, UK and America relating to medicine use
- a new section on COVID-19 national and society guidelines from peak bodies
- additional learning areas addressing sepsis, analgesia, sedation, delirium, inotropes and vasopressors and renal replacement therapies.
The COVID-19 member forum is a platform upon which health professionals can share on-the-ground learnings, warnings and advice as the clinical implications of the virus continue to grow. Join in discussion forum conversations, seek information and use the resources.
- SHPA Members If you want to discuss anything COVID-19 related, please do so in the COVID-19 member forum, so everyone can access, share and learn from the information discussed.
Join the COVID-19 member forum by logging into Online CPD →
- Not an SHPA Member? Non-members can request access to the forum by emailing email@example.com.
Understanding and knowledge of COVID-19 is evolving rapidly. While the content presented in these webinars was current at the time of presentation, SHPA urges all pharmacists to be mindful of the webinar dates when considering or utilising information.
- COVID-19: Challenges in Cancer
This webinar will overview current literature and recommendations for the management of cancer patients during the COVID-19 pandemic. It will include shared experiences, practical strategies for managing staff and optimisation of patient care during these challenging times.
1.00–2.00pm AEST, Tuesday 12 May 2020
Register now →
- The COVID-19 Pandemic: What comes next?
In this webinar the NSW Branch will host Professor Daniel Bausch, one of the world’s leading virologists, as he reflects on his 25 years of fighting outbreaks and looks into his crystal ball to discuss what comes next in the global fight against COVID-19.
7.00–8.00pm AEST, Wednesday 13 May 2020
Register now →
- COVID-19: SHPA Advocacy
An overview of SHPA’s current COVID-19 related advocacy work.
1.00–2.00pm AEST, Tuesday 19 May 2020
Register now →
This webinar replay covers key concepts, import practice points and some clinical pearls on the complex topic of inotrope and vasopressor infusions.
Member view via Online CPD →
On Tuesday 12 May we announced the release of a new section on optimal management of injectable medicines for Australians with COVID-19 disease, as part of an update to the Australian Injectable Drugs Handbook (AIDH). The new section lists how key medicines and important medical equipment can be managed or prioritised as part of Australia’s preparations and national response to COVID-19.
Emergency supply provisions announced in late March will allow continuity of treatment for outpatients who regularly obtain medicines from hospital outpatient pharmacies and fast-track the discharge process, while in early April, the Federal Government announced a new legislative instrument which enables hospital pharmacists to supply PBS medicines using digital image prescriptions, and which aims to minimise hospital foot traffic and protect hospital inpatients.
To help members navigate the newly authorised provisions, SHPA has developed a set of Quick Guides which provide information and guidance relevant to different jurisdictions. SHPA's Quick Guides will be updated regularly, and we recommend they be read in conjunction with specific laws in each jurisdiction, and that members are mindful of the 'last updated' date reference.
- ACT: Chief Medical Officer alerts
- Northern Territory: COVID-19 information (general)
- NSW: COVID-19: Updated advice for health professionals
- Queensland: Information for Queensland clinicians and healthcare workers
- South Australia: Coronavirus disease 2019 (COVID-19): information for health professionals
- Tasmania: COVID-19 information (general)
- Victoria: For health services and general practitioners – coronavirus disease (COVID-19)
- Western Australia: Coronavirus (COVID-19)
The TGA continues to closely monitor medicine supply to Australian consumers.
COVID-19 related scheduling amendments
Tuesday 24 March 2020
Scheduling entries for hydroxycholoroquine and salbutamol (Ventolin) has changed overnight. Poisons for which the initial treatment of a patient has been authorised following the commencement of the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020 by a medical practitioner, recognised under State or Territory legislation that forms part of the Health Practitioner Regulation National Law, as a specialist in any of the following specialties:
(b) intensive care medicine;
(c) paediatrics and child health;
(e) emergency medicine.
SALBUTAMOL as the only therapeutically active substance:
a) in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or
b) in dry powders for inhalation delivering 200 micrograms or less of salbutamol per dose; and where supply is limited:
c) to persons with evidence of a medically diagnosed lung condition; or
d) to persons with a record of previous supply from the pharmacist; or
e) to persons authorised under a law of a State or Territory to use or supply salbutamol in the practice of their profession; or
f) for use in institutional first aid; and where paragraph (c) or (d) applies—supply is limited to one primary pack of salbutamol per person.
Following advice and information provided by both Australian federal and state government authorities, all SHPA face-to-face national CPD events and ClinCATs have been postponed.
SHPA remains committed to implementing all recommended precautions from the World Health Organization and Australian federal and state health authorities, and will encourage all attendees to follow these guidelines, which will be communicated to all attendees prior to and during scheduled events.
The implications of the COVID-19 pandemic are not limited to health or economics, and SHPA is committed to supporting the mental health wellbeing of our members, their colleagues and the Australians in their care. Below are some resources which could be of help in looking after your mental health and wellbeing:
Mental health services and resources
- Pharmacist Support Services offers support relating to the many demands of faced by pharmacists, pharmacy interns and students. Their team of volunteer pharmacists, trained in peer support and telephone counselling, is available every day of the year on 1300 244 910, from 8.00am to 11.00pm AEDT.
- Webinar: COVID-19 – From surviving to thriving (8pm AEST, Tuesday 7 April)
Co-hosted by PSS and AJP and presented by pharmacist and counsellor and SHPA Member Helen Lowy, this webinar will provide pharmacists and pharmacy staff with a pandemic survival toolkit, including practical tips on caring for yourself, your teams and keeping your workplaces safe.
As posted to the SHPA COVID-10 member forum by Kay Dunkley, Executive Officer, Pharmacists’ Support Service on Tuesday 24 March.
Ensuring all staff are supported to manage their mental health and overall well-being during the COVID-19 pandemic will be crucial to ensure that safe practice is maintained at all times. Protecting mental health keeps us all functioning at our peak. Humans are hardwired to be afraid of the unknown and of something that appears random and uncontrollable. The COVID-19 pandemic is an unprecedented event for us all. Despite education and knowledge, health professionals including pharmacists are just as likely to be feeling anxious as anyone else. Hence the following suggestions.
Practical ways to manage your mental health during this time
- Be self-aware and recognise those things that may be causing you stress and your own warning signs of stress
- Be aware of your own critical eye and have some self-compassion, don’t be so hard on yourself when things do not go according to plan
- Get enough rest during work hours and between shifts
- Pace yourself, this is likely to be a marathon
- Speak up if your workload is not manageable
- Eat healthy foods and engage in physical activity
- Keep in contact with colleagues, family and friends by phone or online
- Don’t use smoking, alcohol or other drugs to deal with your emotions
- Be aware of where you can access mental health support at work e.g. The eap or other services such as PSS: 1300 244 910
- If you’re a manager, try to create mentally healthy work rosters and workloads, encourage teamwork and support anyone who may be struggling.
Maintaining a healthy outlook
- To relax outside work, try to do something totally unrelated to work every day which distracts you and makes you smile, even for a short period of time. Intentionally take some time out to disconnect from the news, social media, politicians, constant case updates and other sources of information about COVID-19.
- If you sense your anxiety is getting a bit out of hand reach out for help to debrief. Access your support network – these could be friends, family and work colleagues or the PSS, as well as professional supports such as your GP or psychologist – and let them know how you are feeling.
- Draw on skills you have used in the past to help manage previous life adversities. Think about what has helped before and how you can apply these strategies now. This could be as simple as breathing techniques to slow your heart rate and stop you becoming over-whelmed. Other stress reducing activities may be regular walks in nature or some physical exercise.
- Speak to a psychologist or counsellor if your usual methods of managing stress are not working; they can help you develop other strategies to manage stress.
- Try to practise kindness and compassion in all aspects of your life. Be extra nice to your colleagues and other staff in the workplace.
- Beyond Blue has established the Coronavirus Mental Wellbeing Support Service, a free, 24/7 support service
- Monash University – Mental health and resilience in the time of COVID-19, Emily Berger, Monash Lens
- The Royal Australian and New Zealand College of Psychiatrists – Taking care of your mental health and wellbeing during COVID-19 fears
- WHO – Mental Health and Psychosocial Considerations During COVID-19 Outbreak
- Australian Academy of Science – Isolation and anxiety: Strategies to cope during COVID-19
- Flinders University – Mental health advice amid COVID-19 concerns
- State governments: ACT; NSW; NT; Qld; SA; Tas; Vic; WA;
- WHO – Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19)
Ahpra and the National Boards are committed to supporting health practitioners to continue to provide safe care to their communities and will continue to update health practitioners and the public with information as it becomes available. All COVID-19 related updates from Ahpra and the National Boards can be found on their website and include:
- COVID-19 frequently asked questions – Ahpra and the National Boards address a range of questions about how the Boards would respond to requests for changes to the way that they register individuals in the context of managing the health sector impacts of COVID-19
COVID-19 update on supervised practice and registration examinations for interns
The Pharmacy Board of Australia (the Board) has announced its decision to modify some of the requirements for general registration during COVID-19. These are interim arrangements which apply only during COVID-19 and relate to: supervised practice, examinations for general registration (written and oral), and June and October 2020 oral exams.
- COVID-19 updates in leading medicines resource – Tuesday 12 May 2020
- Medicines supply key to opening COVID-safe economy – Thursday 7 May 2020
- President inspires in COVID-19 address – Tuesday 5 May 2020
- SHPA welcomes greater flexibility for interns – Friday 1 May 2020
- Australia’s real COVID-19 risk is medicines, not ventilators – Monday 27 April 2020
- ‘Telepharmacy’ will protect Australians in isolation and our hospitals during COVID-19 – Friday 17 April 2020
- Federal digital image prescription changes welcome, further states' support needed – Thursday 9 April 2020
- Hospital pharmacists in new national taskforce to support clinicians providing COVID-19 care – Saturday 4 April 2020
- SHPA welcomes Ahpra boost to potential hospital workforce – Wednesday 1 April 2020
- SHPA welcomes emergency measures in three states to support medicines supply during COVID-19 – Friday 27 March 2020
- Rapid nationwide response as pharmacists rush to join hospital relief register – Monday 23 March 2020
- Call for pharmacists to join hospital relief register ahead of COVID-19 staffing impact – Friday 20 March 2020
- Call to green light pharmacist teleconsults to aid isolated Australians, and hospitals, amid COVID-19 crisis – Friday 20 March 2020
- $2.4bn package welcomed as SHPA urges calm on COVID-19 – Wednesday 11 March 2020
SHPA office closure
The SHPA office is currently closed with staff working remotely. Until further notice, the SHPA Secretariat landline will not be in use, please direct enquiries to firstname.lastname@example.org or directly to relevant SHPA staff via email or mobile.
- Kristin Michaels, Chief Executive: 0408 399 505, email@example.com
- Johanna de Wever, General Manager, Advocacy and Leadership: 0487 698 218, firstname.lastname@example.org
- Dan Guidone, Head of Pharmacy Futures: 0416 024 406, email@example.com
- Sally Ridgers, General Manager, Education Services: 0438 074 348, firstname.lastname@example.org
- Nick Sharp-Paul, Head of Strategy and Communication: 0411 098 838, email@example.com